Drug intelligence / Profile preview

hyaluronic acid + lidocaine (Aowita)

Development stage
Unknown
Lead developer
Aowita
Modality
Small Molecules
Administration
Subcutaneous, Intramuscular
01

Overview

Rveiling + Lidocaine is a cross-linked hyaluronic acid dermal filler combined with 0.3% lidocaine hydrochloride, developed by Aowita Biotech. The product utilizes a patented cross-linking technology involving natural entanglement of high molecular weight hyaluronic acid and chemical modification with BDDE to create a stable, three-dimensional gel matrix. This structure resists enzymatic degradation, providing long-lasting volume for tissue augmentation, structural support, and aesthetic contouring. The inclusion of lidocaine serves as a local anesthetic to reduce pain and discomfort during the injection process. It is indicated for deep subcutaneous or superficial periosteal injection for applications such as buttock augmentation, facial volumization, and hand rejuvenation.

Brand names
Rveiling
Other names
cross-linked sodium hyaluronate + lidocaine hydrochlorideRveiling Cross Linked Hyaluronic Acid With Lidocaine For Buttocks
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on hyaluronic acid + lidocaine (Aowita).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + lidocaine (Aowita).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call